超越三次卵与寄生虫检查
本文综述指出,美国常规多次卵与寄生虫检查(O&P×3)用于持续或慢性腹泻评估时结果几乎总为阴性,导致寄生虫病被误认为罕见;来自第三世界国家的移民、游客和学生出现寄生虫病症状时常被误诊为肠易激综合征或炎症性肠病。某些寄生虫病在美国等发达国家呈地方性流行,影响免疫正常和免疫抑制患者,适当的O&P或其他诊断检查后给予推荐治疗获益明显,大多数寄生虫病易于治疗,不应与其他慢性胃肠道疾病混淆。
要点
- 美国常规O&P×3评估持续或慢性腹泻结果几乎总为阴性,造成寄生虫病罕见的错觉。
- 来自第三世界国家的移民、游客和学生出现寄生虫病症状时常被误诊为肠易激综合征或炎症性肠病。
- 某些寄生虫病在美国等发达国家呈地方性流行,影响免疫正常和免疫抑制患者,适当检查后治疗获益明显。
核心结论
- 大多数寄生虫病易于治疗,不应与其他慢性胃肠道疾病混淆;适当的O&P或其他诊断检查后给予推荐治疗获益明显。
研究设计与样本
- 本文为综述,批判性评估腔道寄生虫病的症状学、鉴别诊断、适当诊断检查和管理。
主要发现
- 美国常规多次卵与寄生虫检查(O&P×3)用于持续和/或慢性腹泻评估时结果几乎总为阴性。
- 来自第三世界国家的移民、游客和学生出现寄生虫病症状时常被误诊为肠易激综合征或炎症性肠病。
- 某些寄生虫病在美国和其他发达国家呈地方性流行,影响免疫正常和免疫抑制患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although examination of the stool for ova and parasites times three (O&P ×3) is routinely performed in the United States (US) for the evaluation of persistent and/or chronic diarrhea, the result is almost always negative. This has contributed to the perception that parasitic diseases are nearly non-existent in the country unless there is a history of travel to an endemic area. The increasing number of immigrants from third-world countries, tourists, and students who present with symptoms of parasitic diseases are often misdiagnosed as having irritable bowel syndrome or inflammatory bowel disease. The consequences of such misdiagnosis need no explanation. However, certain parasitic diseases are endemic to the US and other developed nations and affect both immunocompetent and immunocompromised patients. Testing for parasitic diseases either with O&P or with other diagnostic tests, followed by the recommended treatment, is quite rewarding when appropriate. Most parasitic diseases are easily treatable and should not be confused with other chronic gastrointestinal (GI) disorders. In this review, we critically evaluate the symptomatology of luminal parasitic diseases, their differential diagnoses, appropriate diagnostic tests, and management.
引用
- Mohapatra S, Singh DP, Alcid D, et al. Beyond O&P Times Three. Am J Gastroenterol. 2018. PMID: 29867172. doi:10.1038/s41395-018-0083-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。